ICU Medical, Inc. (FRA:IC7)

Market Cap	3.11B
Revenue (ttm)	1.98B
Net Income (ttm)	-6.27M
Shares Out	n/a
EPS (ttm)	-0.27
PE Ratio	n/a
Forward PE	19.37
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	11
Open	129.00
Previous Close	128.00
Day's Range	125.00 - 129.00
52-Week Range	92.00 - 164.00
Beta	n/a
RSI	66.99
Earnings Date	Feb 27, 2026

About ICU Medical

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. It offers infusion therapy products, such as needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard,...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1984
• Employees: 15,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: IC7

Financial Performance

In 2024, ICU Medical's revenue was $2.38 billion, an increase of 5.44% compared to the previous year's $2.26 billion. Losses were -$117.69 million, 296.9% more than in 2023.

Financial numbers in USD